FDA Looks To Placate Amarin, Duck Free Speech Decision
The U.S. Food and Drug Administration in a letter released Monday told Amarin Pharma Inc. it can make numerous off-label statements about fish oil medicine Vascepa, a move likely designed to...To view the full article, register now.
Already a subscriber? Click here to view full article